Gland Pharma Limited (BOM:543245)
India
· Delayed Price · Currency is INR 1,580.75
+55.80 (3.66%)
At close: May 29, 2025
Gland Pharma Revenue
In the fiscal year ending March 31, 2025, Gland Pharma had annual revenue of 56.17B INR, down -0.85%. Gland Pharma had revenue of 14.25B in the quarter ending March 31, 2025, a decrease of -7.32%.
Revenue
56.17B
Revenue Growth
-0.85%
P/S Ratio
4.66
Revenue / Employee
13.10M
Employees
4,286
Market Cap
261.73B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |